2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics

BCSCP Board Certified Sterile Compounding Pharmacist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, USP Standards & CSP Categories

1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions

2 Chapter 2: Facilities, Engineering Controls & Cleaning

2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

3 Chapter 3: Environmental Monitoring & Facility Certification

3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols

4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique

4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

5 Chapter 5: Beyond-Use Dating, Storage & Container Rules

5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules

6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding

6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)

7 Chapter 7: Materials, Equipment & Compounding Workflow

7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs

8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility

8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics

9 Chapter 9: Therapeutics, Administration & Patient Monitoring

9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations

10 Chapter 10: Quality Management, Records & Personnel Competency

10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence

11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain

11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA

12 Chapter 12: Safety Management, Investigations, Recalls & Waste

12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management

2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics

Key Takeaways Explain This Topic AI

A Primary Engineering Control (PEC) provides the ISO Class 5 environment for sterile compounding and must deliver HEPA-filtered unidirectional airflow fast enough to sweep particles away from critical sites.

Horizontal Laminar Airflow Workstations (LAFWs) direct HEPA-filtered air toward the operator, offering product protection for non-hazardous compounding but no operator containment.

Class II Biological Safety Cabinets (types A2, B1 or B2) and compounding aseptic containment isolators (CACIs) are the externally vented C-PEC options for sterile hazardous drug compounding under USP <800>.

CAIs and CACIs are restricted-access barrier systems (RABS). In an unclassified SCA they may be used only for Category 1 CSPs; for Category 2 or 3 they must sit in a cleanroom suite.

Last updated: September 2026

Primary Engineering Controls: The Core ISO Class 5 Barrier

A Primary Engineering Control (PEC) is a specialized enclosure designed to provide an ISO Class 5 environment for sterile compounding. The PEC protects the Direct Compounding Area (DCA)—the specific point where critical sites (open ampules, vial stoppers, needle hubs) are exposed to air.

HEPA Filtration Mechanics

All PECs rely on High-Efficiency Particulate Air (HEPA) filters . A certified HEPA filter must remove at least 99.97% of airborne particles as small as 0.3 μ m 0.3\,\mu\text{m} 0.3 μ m in diameter . Particles 0.3 μ m 0.3\,\mu\text{m} 0.3 μ m represent the Most Penetrating Particle Size (MPPS) ; particles larger or smaller than 0.3 μ m 0.3\,\mu\text{m} 0.3 μ m are captured with even greater efficiency via impaction, interception, and Brownian diffusion.

Laminar Airflow and "First Air"

Laminar Flow : Air moves in parallel, uniform streamlines. USP <797> requires only a velocity high enough to sweep particles away from critical sites and keep the flow unidirectional during operations. For laminar airflow workbenches, certifiers have long used 90 feet per minute ± 20 % 90\,\text{feet per minute} \pm 20\% 90 feet per minute ± 20% ( 0.45 m/s ± 20 % 0.45\,\text{m/s} \pm 20\% 0.45 m/s ± 20% ) as the benchmark. BSC downflow and inflow velocities follow the cabinet's NSF/ANSI 49 listing and the manufacturer's specifications.

First Air : The pristine, HEPA-filtered air exiting the filter face before it encounters any equipment, container, or personnel hand. Critical compounding sites must receive unobstructed First Air at all times to prevent contamination from downstream wake turbulence.

Comparison of PEC Types and Engineering Designs

Clinical pharmacy specialists must select the appropriate PEC based on the hazardous properties, chemical volatility, and sterility requirements of the drug preparation.

PEC Classification Airflow Direction Recirculation % Operator Containment? Authorized Uses under USP <797> & <800>

Horizontal LAFW (HLAFW) Horizontal (rear HEPA filter forward toward user) 0% (blows out to room) NO (blows directly at operator) Non-hazardous sterile compounding ONLY . Strictly prohibited for hazardous drugs.

Vertical LAFW (VLAFW) Vertical (ceiling HEPA filter down toward deck) Variable (deck return) NO (deflects off deck toward user) Non-hazardous sterile compounding ONLY . Prohibited for hazardous drugs.

Class II Type A2 BSC Vertical downflow; front air curtain grille About 70% recirculated / 30% exhausted YES (inflow barrier; exhaust canopy-connected to outside for HDs) Acceptable C-PEC for most sterile HDs; also used for non-hazardous CSPs.

Class II Type B1 BSC Vertical downflow; split plenums 30% recirculated / 70% exhausted YES (dedicated hard duct) Hazardous sterile compounding with minute volatile agents.

Class II Type B2 BSC Vertical downflow; total exhaust 0% recirculated / 100% hard-ducted YES (full exhaust protection) Typically reserved for HDs with volatile components (USP <800>).

Compounding Aseptic Isolator (CAI) Positive pressure unidirectional downflow Recirculated through internal HEPA NO (protects product only) Non-hazardous CSPs ; SCA placement limits CSPs to Category 1; never for antineoplastic HDs.

Compounding Aseptic Containment Isolator (CACI) Negative pressure unidirectional downflow 100% externally vented YES (negative pressure containment) Hazardous sterile compounding in cleanrooms or C-SCAs.

Warning

LAFW and CAI Prohibition: Under USP <800>, a laminar airflow workbench (horizontal or vertical) or a compounding aseptic isolator (CAI) must never be used to compound an antineoplastic hazardous drug. In a horizontal LAFW the HEPA filter is at the back of the cabinet, so air sweeps across the vials and straight into the operator's breathing zone.

Biological Safety Cabinets (Class II Types) in Hazardous Compounding

Class II Biological Safety Cabinets are the workhorse engineering controls for hazardous sterile compounding. They maintain an ISO Class 5 sterile work zone while simultaneously establishing a protective negative-pressure air barrier across the front sash to protect personnel.

Airflow Barrier (Air Curtain): Room air is drawn into the front intake grille at high velocity ( 100 to 110 ft/min 100\text{ to }110\,\text{ft/min} 100 to 110 ft/min ), preventing hazardous vapors from escaping into the room and preventing unfiltered room air from invading the work deck.

Class II Type A2 Cabinets: Draw approximately 70% of downflow air through an internal HEPA filter back into the work zone, while discharging 30% through an exhaust HEPA filter. When used for sterile hazardous drugs, the exhaust must be vented outside, usually through a canopy (thimble) connection . USP <800> accepts Types A2, B1 and B2 and notes that A2 cabinets integrate most simply with C-SEC ventilation for most known HDs.

Class II Type B2 Total Exhaust Cabinets: Feature zero air recirculation. All downflow air is drawn from the room or dedicated HVAC supply, passed once over the work deck, filtered through an exhaust HEPA, and immediately expelled through dedicated hard ductwork to the building exterior. Because drug vapors pass straight through HEPA filters, USP <800> says Type B2 cabinets are typically reserved for HDs with volatile components. It does not make them mandatory for every HD.

Aseptic Workspace Staging and Airflow Integrity

Preserving ISO Class 5 laminar airflow requires disciplined physical staging on the cabinet work deck:

The Six-Inch Rule: Compounding manipulations must be performed at least 6 inches ( 15 cm 15\,\text{cm} 15 cm ) inside the front outer edge of the work deck. Within the first 6 inches, room air collides with laminar downflow, creating an unstable turbulent transition zone vulnerable to ambient contamination.

Keep Clear of the Walls: Many training programs keep supplies a few inches from the side walls and back partition, because air slows and swirls along those surfaces.

Preserving Airflow Grilles: Never place items, paper wrappers, gauze packs, or hands over the front intake grilles or rear exhaust perforations. Blocking grilles disrupts internal negative pressure, causing cabinet containment failure.

Cleaning the Cabinet: On compounding days, the PEC's interior surfaces and equipment are cleaned and disinfected daily with sterile agents, and a sporicidal is applied at least monthly (see 2.6). Sterile 70% IPA goes on the work surface just before compounding and at least every 30 minutes during a session. Wipe in overlapping strokes from cleanest to dirtiest: away from the HEPA filter in a horizontal hood, and top to bottom, back to front, in a vertical hood.

Clinical Practice Scenario: Airflow Smoke Pattern Visualization Failure

During semiannual certification, a cleanroom certification technician conducts a smoke pattern test (airflow visualization study) inside a biological safety cabinet under dynamic operating conditions. When smoke is released at the work deck, smoke streams are observed billowing forward through the sash opening into the operator zone.

Investigation reveals that the compounding technician had placed a large automated compounding device (ACD) pump and three 1-liter IV fluid bags directly over the rear exhaust vents and within 2 inches of the front sash grille. This blockage disrupted the cabinet's laminar downflow, creating severe eddy currents that overwhelmed the front air barrier.

The Designated Person immediately halted compounding, quarantined all preparations compounded during that shift, and re-staged the workspace: the ACD was repositioned to the far side of the work zone, fluid bags were elevated on IV poles to allow First Air to sweep beneath them, and grilles were cleared. A repeat smoke test verified smooth, unidirectional laminar flow with zero outward turbulence.